Patritumab Deruxtecan: 9 Clinical Trials

HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer

Condition(s):Non-Small Cell Lung Cancer Metastatic; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorLast Updated:May 11, 2022Recruiting

A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

Condition(s):Nonsquamous Non-small Cell Lung Cancer; EGFR L858RLast Updated:May 24, 2022Recruiting

Patritumab Deruxtecan in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer

Condition(s):Non-Small Cell Lung Cancer (NSCLC)Last Updated:November 5, 2021Recruiting

Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer

Condition(s):Metastatic Breast CancerLast Updated:July 16, 2021Recruiting

A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression

Condition(s):Breast CancerLast Updated:April 4, 2022Recruiting

A Study of U3-1402 in Subjects With Metastatic Breast Cancer

Condition(s):Metastatic Breast CancerLast Updated:January 12, 2022Recruiting

Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer

Condition(s):Metastatic Breast CancerLast Updated:November 16, 2021Active, not recruiting

U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer

Condition(s):Non-Small Cell Lung Cancer (NSCLC)Last Updated:April 28, 2022Active, not recruiting

A Study to Evaluate U3-1402 in Subjects With Advanced or Metastatic Colorectal Cancer

Condition(s):Metastatic Colorectal CancerLast Updated:April 15, 2022Terminated

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.